Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heterocyclic azaindane carboxamide CGRP receptor antagonists

Fused heterocyclic azaindane carboxamide CGRP receptor antagonists

US Patent 9067941 · Granted Jun 30, 2015

Estimated economic value: $198,063,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolidine orexin receptor agonists2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
MrgX2 antagonists2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2021
Bicyclic heterocyclic compounds as PDE2 inhibitors2019
Piperidinone carboxamide azaindane CGRP receptor antagonists2019
Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2019
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2018